OTC Drug Ads Rarely Mention Risks, Study Finds

Law360, New York (September 12, 2012, 8:48 PM EDT) -- Drug advertisements referenced a treatment's risks far less frequently when it was sold over-the-counter than when it was sold by prescription, according to a study published Wednesday, a disparity that could be attributable to the different regulations governing the types of drugs.

A drug's potential harms were mentioned in 70 percent of the print and broadcast prescription-drug advertisements examined in a Journal of the American Medical Association study, but in just 11 percent of over-the-counter drug advertisements.

The U.S. Food and Drug Administration regulates advertisements for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.